Denali Therapeutics
DNLI
#3996
Rank
โ‚ฌ2.49 B
Marketcap
15,74ย โ‚ฌ
Share price
-7.98%
Change (1 day)
19.75%
Change (1 year)

EPS for Denali Therapeutics (DNLI)

EPS in 2025 (TTM): -2,58ย โ‚ฌ

According to Denali Therapeutics 's latest financial reports the company's current EPS (TTM) is -2,57ย โ‚ฌ. In 2024 the company made an earnings per share (EPS) of -2,23ย โ‚ฌ a decrease over its 2023 EPS that were of -0,90ย โ‚ฌ.

EPS history for Denali Therapeutics from 2017 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-2,58ย โ‚ฌ15.97%
2024-2,23ย โ‚ฌ147.12%
2023-0,90ย โ‚ฌ-60%
2022-2,25ย โ‚ฌ8.79%
2021-2,07ย โ‚ฌ-712.82%
20200,34ย โ‚ฌ-118.93%
2019-1,79ย โ‚ฌ402.44%
2018-0,36ย โ‚ฌ-88.89%
2017-3,20ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Organovo
ONVO
-9,99ย โ‚ฌ 287.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Orchard Therapeutics
ORTX
-6,16ย โ‚ฌ 139.06%๐Ÿ‡ฌ๐Ÿ‡ง UK
Novavax
NVAX
1,84ย โ‚ฌ-171.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Novocure
NVCR
-1,40ย โ‚ฌ-45.79% Jersey